Latest & greatest articles for copd

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on copd or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on copd and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for copd

361. A COPD self management programme reduced hospital use and improved health status

A COPD self management programme reduced hospital use and improved health status A COPD self management programme reduced hospital use and improved health status | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A COPD self management programme reduced hospital use and improved health status Article Text Treatment A COPD self management programme reduced hospital use and improved health status Free Haleema Shakur , RGN, MSc Statistics from

Full Text available with Trip Pro

2004 Evidence-Based Nursing

362. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis

Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis Salpeter SR, Ormiston TM, Salpeter EE CRD summary This review concluded that the use of beta2-agonists in individuals with obstructive airway disease increases the risk for adverse cardiovascular events. While the authors (...) obstructive pulmonary disease (COPD), were eligible for inclusion. Apart from one study of both asthma and COPD participants, the included studies were of either asthma or COPD participants alone. The mean age of the participants was 56.6 years in single-dose studies and 52.2 years in studies of longer duration. Outcomes assessed in the review Single-dose studies were eligible for inclusion if they provided extractable data on heart rate or potassium concentrations. Longer duration trials were eligible

Full Text available with Trip Pro

2004 DARE.

363. Hospital technology at home: portable oxygen therapy in COPD

Hospital technology at home: portable oxygen therapy in COPD Hospital technology at home: portable oxygen therapy in COPD Hospital technology at home: portable oxygen therapy in COPD Law S, Lehoux P Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Law S, Lehoux P. Hospital technology at home: portable oxygen therapy in COPD. Montreal (...) : Agence d'evaluation des technologies et des modes d'intervention en sante (AETMIS). AETMIS 04-03. 2004 Authors' objectives The objectives of this report are the following: 1) to summarize published data about a) the effectiveness and use of portable oxygen therapy in the treatment of patients with chronic obstructive pulmonary disease (COPD) associated with severe hypoxaemia, b) different health-care organization models, and c) the cost effectiveness and quality of the care provided to these patients

2004 Health Technology Assessment (HTA) Database.

364. Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. (PubMed)

Secular trends in nosocomial infections and mortality associated with noninvasive ventilation in patients with exacerbation of COPD and pulmonary edema. Randomized controlled trials have shown that the use of noninvasive ventilation (NIV) reduces the need for endotracheal intubation and invasive mechanical ventilation and reduces complication rates and mortality in selected groups of patients. But whether these benefits translate to a clinical setting is unclear.To evaluate longitudinally (...) the routine implementation of NIV and its effect on patients admitted to the intensive care unit (ICU) with acute exacerbation of chronic obstructive pulmonary disease (COPD) or severe cardiogenic pulmonary edema (CPE).Retrospective, observational cohort study using prospectively collected data from January 1, 1994, through December 31, 2001.A 26-bed medical intensive care unit (ICU) of a French university referral hospital.A cohort of 479 consecutive patients ventilated for acute exacerbation of COPD

Full Text available with Trip Pro

2003 JAMA

365. Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis

Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Domiciliary non-invasive ventilation for recurrent acidotic exacerbations of COPD: an economic analysis Tuggey J M, Plant P K, Elliott M W Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief (...) summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of domiciliary noninvasive ventilation (NIV) for the management of patients with recurrent admissions because of an acidotic exacerbation of chronic obstructive pulmonary disease (COPD). Type of intervention Treatment. Economic study type Cost-effectiveness analysis. Study population The study population comprised patients

2003 NHS Economic Evaluation Database.

366. Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma

Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma Levalbuterol compared to racemic albuterol: efficacy and outcomes in patients hospitalized with COPD or asthma Truitt T, Witko J, Halpern M Record Status This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract (...) contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The use of racemic albuterol (RA) versus levalbuterol (LEV) for the inpatient treatment of patients with chronic obstructive pulmonary disease (COPD) or asthma. The patients in the RA group were treated with a target care path of 2.5 mg every 4 hours and as medically necessary. The patients in the LEV group were

2003 NHS Economic Evaluation Database.

367. Oxygen versus medical air for nebulisers in patients with COPD

Oxygen versus medical air for nebulisers in patients with COPD Oxygen versus medical air for nebulisers in patients with COPD Oxygen versus medical air for nebulisers in patients with COPD Higgins S Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Higgins S. Oxygen versus medical air for nebulisers in patients with COPD. Clayton, Victoria: Centre for Clinical (...) Effectiveness (CCE) 2003: 8 Authors' objectives This aim of this critical appraisal was to assess whether chronic obstructive pulmonary disease (COPD) patients that have a hypoxic respiratory drive or retain CO2 be given oxygen or medical air to vaporize nebulised therapy. Project page URL Indexing Status Subject indexing assigned by CRD MeSH Nebulizers and Vaporizers; Oxygen; Pulmonary Disease, Chronic Obstructive Language Published English Country of organisation Australia Address for correspondence

2003 Health Technology Assessment (HTA) Database.

368. Inhaler devices for the management of asthma and COPD

Inhaler devices for the management of asthma and COPD Inhaler devices for the management of asthma and COPD Inhaler devices for the management of asthma and COPD Centre for Reviews and Dissemination Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Centre for Reviews and Dissemination. Inhaler devices for the management of asthma and COPD (...) . University of York. Effective Health Care 8(1). 2003 Authors' objectives This Effective Health Care bulletin summarises the research evidence on inhaler devices for the management of asthma and chronic obstructive pulmonary disease (COPD). Authors' conclusions - Asthma and chronic obstructive pulmonary disease (COPD) are common diseases of the airways and lungs that have a major impact on the health of the population. A key component of the management of these conditions involves the inhalation

2003 Health Technology Assessment (HTA) Database.

369. Tiotropium: a potential replacement for ipratropium in patients with COPD

Tiotropium: a potential replacement for ipratropium in patients with COPD Tiotropium: a potential replacement for ipratropium in patients with COPD Tiotropium: a potential replacement for ipratropium in patients with COPD Shukla V K Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Shukla V K. Tiotropium: a potential replacement (...) for ipratropium in patients with COPD. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA) 2002: 4 Authors' objectives To summarise the available evidence on tiotropium as a potential replacement for ipratropium in patients with chronic obstructive pulmonary disease. Authors' conclusions - Inhaled tiotropium provides a sustained bronchodilator effect over a 24-hour period in patients with chronic obstructive pulmonary disease (COPD). - There is some evidence that tiotropium 18g once

2002 Health Technology Assessment (HTA) Database.

370. Effects of physical activity in mild to moderate COPD: a systematic review

Effects of physical activity in mild to moderate COPD: a systematic review Effects of physical activity in mild to moderate COPD: a systematic review Effects of physical activity in mild to moderate COPD: a systematic review Chavannes N, Vollenberg J J, van Schayck C P, Wouters E F Authors' objectives To investigate the efficacy of physical activity on functional status and prognosis in patients with mild to moderate chronic obstructive pulmonary disorder (COPD). Searching MEDLINE (from 1983 (...) to November 1999), EMBASE (from 1984 to 2000) and the Cochrane Library (Issue 1, 2000) were searched using the following search terms: 'COPD', 'chronic obstructive pulmonary disease', 'chronic bronchitis' and 'emphysema', combined with 'physical activity', 'exercise', 'sports' and 'training'. Review articles and the reference lists of selected studies were also examined. Only studies reported in Dutch or English were eligible for inclusion. Study selection Study designs of evaluations included

2002 DARE.

371. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review.

The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Rose C (...) , Wallace L, Dickson R, Ayres J, Lehman R, Searle Y, Burge P S Authors' objectives To investigate whether psychological interventions are effective methods of reducing anxiety and panic in patients with chronic obstructive pulmonary disease (COPD). Searching MEDLINE, PsycLIT, CINAHL, ASSIA, the National Research Register, ISI (via BIDS), EMBASE, ClinPSYC, the Cochrane Controlled Trials Register, Dissertation Abstracts Online, Networked Digital Library of Theses and Dissertations, and the British Index

2002 DARE.

372. Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis

Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis Effects of controlled inspiratory muscle training in patients with COPD: a meta-analysis Lotters F, van Tol B, Kwakkel G, Gosselink R Authors' objectives To assess the effectiveness of inspiratory muscle training (IMT) in patients with chronic obstructive pulmonary disease (COPD), and to determine which patient (...) investigating the use of IMT at an intensity of greater than or equal to 30% maximum static inspiratory alveolar pressure (PImax) were eligible for inclusion. Two types of inspiratory muscle loading were used in the included studies: targeted resistive training (5 studies) and training with a threshold loading device (10 studies). In 6 studies IMT was added to general exercise reconditioning. Participants included in the review Studies with participants who had COPD were eligible for inclusion

2002 DARE.

373. Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy

Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy Impact of a hospital-based home-care program on the management of COPD patients receiving long-term oxygen therapy Farrero E, Escarrabill J, Prats E, Maderal M, Manresa F Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The health technology assessed in the paper was a hospital-based home care programme (HCP) for the management of patients suffering from COPD, a progressive disease with frequent exacerbations. The HCP was designed to combine management at home and easy access to hospital resources

2001 NHS Economic Evaluation Database.

374. Tiotropium for COPD - horizon scanning review

Tiotropium for COPD - horizon scanning review Tiotropium for COPD - horizon scanning review Tiotropium for COPD - horizon scanning review NHSC Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation NHSC. Tiotropium for COPD - horizon scanning review. Birmingham: National Horizon Scanning Centre (NHSC). New and Emerging Technology Briefing. 2001 (...) Authors' objectives To summarise the current research evidence on tiotropium (Spiriva) for chronic obstructive pulmonary disease (COPD). Authors' conclusions - Clinical impact: Tiotropium has shown significant improvements in lung function compared to ipratropium. Clinical trials have also found significant long-term benefits in terms of dyspnoea and health status with a reduction in exacerbations. Tiotropium with its once a day administration may also increase patient compliance. - Service impact

2001 Health Technology Assessment (HTA) Database.

375. Management of acute exacerbations of COPD: a summary and appraisal of published evidence

Management of acute exacerbations of COPD: a summary and appraisal of published evidence Management of acute exacerbations of COPD: a summary and appraisal of published evidence Management of acute exacerbations of COPD: a summary and appraisal of published evidence McCrory DC, Brown C, Gelfand SE, Bach PB Authors' objectives To critically review the available data on the diagnostic evaluation, risk stratification and therapeutic management of patients with acute exacerbations of chronic (...) obstructive pulmonary disease (COPD). Searching MEDLINE (from 1966 to 2000), EMBASE (from 1974 to 2000), HealthSTAR (from 1975 to 2000) and the Cochrane Controlled Trials Register (Issue 1, 2000) were searched. Several search strategies that included the terms 'COPD' and 'acute exacerbations' were employed. The reference lists of retrieved articles were also checked. Study selection Study designs of evaluations included in the review Randomised controlled trials (RCTs) were used, except for some treatment

2001 DARE.

376. Treating asthma and COPD - a systematic review

Treating asthma and COPD - a systematic review Treating asthma and COPD - a systematic review Treating asthma and COPD - a systematic review Broman G, Bahtsevani C, Berg T, Eliasson M, Agens I et al Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Broman G, Bahtsevani C, Berg T, Eliasson M, Agens I et al. Treating asthma and COPD (...) - a systematic review. Stockholm: Swedish Council on Technology Assessment in Health Care (SBU) 2000: 571 Authors' objectives The intent of this report is to assess the scientific evidence underlying current treatment methods for asthma and COPD (chronic obstructive pulmonary disease) in adults and children. The report addresses primary prevention, pharmacological and surgical treatment, patient education, psychological methods, rehabilitation, climate therapy, and alternative medicine. Background

2000 Health Technology Assessment (HTA) Database.

377. What is the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD?

What is the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD? What is the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD? What is the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD? Hender K Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality (...) of this assessment has been made for the HTA database. Citation Hender K. What is the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD? Centre for Clinical Effectiveness (CCE). Evidence Centre Evidence Report. 2000 Authors' objectives This aim of this report was to assess the optimal dose of intravenous corticosteroid for initial management of acute exacerbations of asthma and COPD. Authors' conclusions - One systematic review was identified that met

2000 Health Technology Assessment (HTA) Database.

378. Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD

Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Pharmacoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD Friedman M, Serby C W, Menjoge S S, Wilson J D, Hilleman D E, Witek T J Record Status (...) study type Cost-effectiveness analysis. Study population Patients with COPD. Further details are given in the study sample field below. Setting Hospital. The economic study was performed in New Orleans, USA. Dates to which data relate The effectiveness and resource data were collected in 1994. 1998 prices were used. Source of effectiveness data Effectiveness data were based on a single study (based on two multi-centre safety and outcome trials). Link between effectiveness and cost data The costing

1999 NHS Economic Evaluation Database.

379. Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. (PubMed)

Multicentre randomised placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. International COPD Study Group. The efficacy of inhaled corticosteroids in the treatment of chronic obstructive pulmonary disease (COPD) remains controversial because of a lack of placebo-controlled studies. We compared the effect of inhaled fluticasone propionate with placebo in the treatment of patients with COPD.We used a randomised, double-blind, placebo (...) , respectively). At the end of treatment, patients on fluticasone propionate had increased their 6 min walking distance significantly more than those on placebo (p=0.032). Fluticasone propionate was tolerated as well as placebo, with few adverse effects and without a clinically important effect on mean serum cortisol concentration.Fluticasone propionate may be of clinical benefit in patients with COPD over at least 6 months. Inhaled corticosteroids may have an important role in the long-term treatment

1998 Lancet

380. Revalidatie bij patienten met COPD: een systematische literatuurstudie

Revalidatie bij patienten met COPD: een systematische literatuurstudie Revalidatie bij patienten met COPD: een systematische literatuurstudie Revalidatie bij patienten met COPD: een systematische literatuurstudie Bekkering G E, Cambach W, Hendriks H J, Chadwick-Straver R V, Gosselink R, Jongmans M, Paterson W J, van der Schans C P, Verhoef-de Wijk M C, Decramer M Authors' objectives To assess the efficacy of rehabilitation programmes for patients with chronic obstructive pulmonary disease (COPD (...) ). Searching MEDLINE (from 1982 to current) and the literature files of the Dutch Paramedical Institute (Npi; Physiotherapy Index, Rehabilitation Index and Occupational Index). The following keywords were used (both in English and Dutch): 'CARA', 'COPD', 'chronic bronchitis', 'emphysema', 'RCT', 'clinical trial', 'effect study', 'effectiveness', 'evaluation', 'endurance therapy', 'training', 'movement therapy', 'rehabilitation' and 'physiotherapy'. Bibliographies from retrieved studies were searched

1998 DARE.